End Hep C SF’s Strategic Plan for 2023-2025
We are delighted to share out the findings from the HERO study. A number of End Hep C SF members provided support for this project, including,…
It is an honor to join End Hep C SF (EHCSF) as the initiative’s Strategic Director. I look forward to advancing and evolving EHCSF’s work…
Thank you so much to the Hellman Collaborative Change Initiative for providing us support that allows us to fund three of our community partners! Due…
In 2017, San Francisco’s initiative to locally eliminate hepatitis C virus (HCV) as a public health threat, End Hep C SF, generated an estimate of…
End Hep C SF have an article published in Public Health Reports, Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in…
End Hep C SF is releasing an RFP with two parts—Part A focuses on HCV program revitalization, and Part B focuses on caring for and…
End Hep C SF are delighted to announce the fourth partner organization that will be joining our hep C Community Navigator Program in January 2022.…
End Hep C SF is excited to release our Request for Proposals (RFP), seeking to award up to two mini-grants of up to $40,000 to…
The San Francisco Department of Public Health’s Hepatitis Surveillance Program have announced the posting of the 2018-2019 Hepatitis C Infection Surveillance Report and corresponding summary slides on SFDPH’s website. …
Hi, I’m Brittany, and I’m joining the team as End Hep C SF’s new Strategic Director. I’m beyond thrilled to be part of this revolutionary…
Paid study for people aged 18-30, who inject or have injected drugs in the last 30 days and are living with #hepC, or were cured…
Vital Strategies recently released several fact sheets on COVID-19. Sex Work, COVID-19 and Harm Reduction COVID-19 Stimulant Use and Harm Reduction Handwashing and COVID-19 Prevention…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…
This workgroup is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments…